The clinical meaning of gastric-wall hyperactivity observed on sestamibi cardiac single-photon emission computed tomography

Canadian Association of Radiologists Journal

Volumn 55, Issue 3, 2004, Pages 178-183

  Côté, Christian ^a   Dumont, Marcel ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; CONFERENCE PAPER; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DYSPEPSIA; FEMALE; GASTRIC WALL HYPERACTIVITY; GASTRITIS; GASTROESOPHAGEAL REFLUX; GENERAL PRACTITIONER; HEART CONTRACTION; HEART VENTRICLE WALL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PROSPECTIVE STUDY; QUALITY CONTROL; QUESTIONNAIRE; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STOMACH MOTILITY; STOMACH WALL; SYSTEMATIC REVIEW;

AGED; AGED, 80 AND OVER; CORONARY DISEASE; DYSPEPSIA; EXERCISE TEST; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; STOMACH; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 3242802815     PISSN: 08465371     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Cardiolite kit for the preparation of technetium Tc99m sestamibi for injection [product monograph]. Billerica (Mass.): Dupont Pharmaceuticals Company Medical Imaging; 1998.
2. Braat SH, Leclerq B, Itti R, Lahiri A, Sridhara B, Rigo P. Myocardial imaging with technetium-99m-tetrosfromin: comparison of one-day and two-day protocols. J Nucl Med 1994;35:1581-5.
3. Germano G, Chua T, Kiat H, Areeda JS, Berman DS. A quantitative phantom analysis for artifacts due to hepatic activity in technetium-99m myocardial perfusion SPECT studies. J Nucl Med 1994;35:356-9.
4. Van Dongen A, van Rijk P. Minimizing liver, bowel, and gastric activity in myocardial perfusion SPECT. J Nucl Med 2000;41:1315-7.
5. Middletown GW, Williams JH. Significant gastric reflux of technetium-99m-MIBI in SPECT myocardial imaging. J Nucl Med 1994;35:619-20.
6. Garcia E, Cooke CD, Van Train KF, Folks R, Peifer J, DePuey EG, et al. Technical aspects of myocardial SPECT imaging with technetium-99m sestamibi. Am J Cardiol 1990;66(Suppl):80E-90E.
7. Hurwitz GA, Clark EM, Slomka PJ, Siddiq SK. Investigation of measures to reduce interfering abdominal activity on rest myocardial images with Tc-99M-sestamibi. Clin Nucl Med 1993;18:735-41.
8. Boz A, Karayalçin B. Which is better for inferior wall evaluation: A full or empty stomach? [letter]. J Nucl Med 1996;37:1916-7.
9. Imaging guidelines for nuclear cardiology procedures, part 2. American Society of Nuclear Cardiology. J Nucl Cardiol 1999;6:G47-84.
10. Bradette M, Emond JG. Dyspepsie au Canada: La prise en charge en médecine familiale. Le clinicien 2001: Suppl:2-12.
11. Lewin KJ, Riddell RH, Weinstein WM. Stomach and proximal duodenum: inflammatory and miscellaneous disorders. In: Gastrointestinal pathology and its clinical implications. New York: Igaku-Shoin; 1992. p. 519-27.
12. Agreus L. Socio-economic factors, health care consumption and rating of abdominal symptom severity: a report from The Abdominal Sympton Study. Fam Pract 1993; 10:152-63.
13. Sell AH. Consensus conference. Medical treatment of peptic ulcer disease: practice guidelines. Practice parameters committee of the American College of Gastroenterology. JAMA 1996;275:622-9.
14. Armstrong D. Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol Suppl 1996;31:38-47.
15. Talley NJ, Hunt RH. What role does Helicobacter pylori play in non ulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms. Gastroenterology 1997;113(Suppl):S67-S77.
16. Maublant JC, Gachon P, Moins N. Hexakis (2-methoxy isobutyl-isonitrile) technetium-99m and thallium 201 chloride: uptake and release in cultured myocardial cells. J Nucl Med 1988;29:48-54.
17. Maublant JC, Moins N, Gachon P, Renoux M, Zhang Z, Veyre A. Uptake of technetium-99m teboroxime in cultured myocardial cells: comparison with thallium-201 and technetium-99m-sestamibi. J Nucl Med 1993;34(2): 255-9.
18. Cordobes MD, Starzec A, Maingeon-Delmon L, Blanchot C, Kouyoumdjian JC, Prevost G, et al. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression. J Nucl Med 1996;37:286-8.
19. Delmon-Moingeon LJ, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the cation hexakis (2-methoxyisobutylisonitrile)- technetium-99m by human carcinoma cell line in vitro. Cancer Res 1990;50:2198-202.